BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24190658)

  • 21. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
    Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
    J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation.
    Pothoven KL; Kheradmand T; Yang Q; Houlihan JL; Zhang H; Degutes M; Miller SD; Luo X
    Am J Transplant; 2010 Aug; 10(8):1774-84. PubMed ID: 20626386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
    Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
    Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
    Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
    Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7.2-/- mature dendritic cells generate T-helper 2 and regulatory T donor cells in fetal mice after in utero allogeneic bone marrow transplantation.
    Bhattacharyya S; Cowan MJ
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):657-71. PubMed ID: 16125636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cells with TGF-β1 and IL-2 differentiate naive CD4+ T cells into alloantigen-specific and allograft protective Foxp3+ regulatory T cells.
    Yang H; Cheng EY; Sharma VK; Lagman M; Chang C; Song P; Ding R; Muthukumar T; Suthanthiran M
    Transplantation; 2012 Mar; 93(6):580-8. PubMed ID: 22270834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice.
    Li Y; Chen HL; Bannick N; Henry M; Holm AN; Metwali A; Urban JF; Rothman PB; Weiner GJ; Blazar BR; Elliott DE; Ince MN
    J Immunol; 2015 Feb; 194(3):1011-20. PubMed ID: 25527786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation.
    Xing S; Zhang X; Liu JH; Huang X; Zhou P
    Clin Exp Immunol; 2019 Jan; 195(1):121-131. PubMed ID: 30317551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease.
    Laurence A; Amarnath S; Mariotti J; Kim YC; Foley J; Eckhaus M; O'Shea JJ; Fowler DH
    Immunity; 2012 Aug; 37(2):209-22. PubMed ID: 22921119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immature syngeneic dendritic cells potentiate tolerance to pancreatic islet allografts depleted of donor dendritic cells in microgravity culture condition.
    Stepkowski SM; Phan T; Zhang H; Bilinski S; Kloc M; Qi Y; Katz SM; Rutzky LP
    Transplantation; 2006 Dec; 82(12):1756-63. PubMed ID: 17198272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance.
    Turnquist HR; Raimondi G; Zahorchak AF; Fischer RT; Wang Z; Thomson AW
    J Immunol; 2007 Jun; 178(11):7018-31. PubMed ID: 17513751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
    Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic expansion of donor-derived, naturally occurring CD4(+)Foxp3(+) regulatory T cells reduces acute graft-versus-host disease lethality without abrogating the graft-versus-leukemia effect in murine models.
    Duramad O; Laysang A; Li J; Ishii Y; Namikawa R
    Biol Blood Marrow Transplant; 2011 Aug; 17(8):1154-68. PubMed ID: 21145405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonmyeloablative allogeneic bone marrow transplantation as immunotherapy for hematologic malignancies and metastatic solid tumors in preclinical models.
    Prigozhina TB; Gurevitch O; Morecki S; Yakovlev E; Elkin G; Slavin S
    Exp Hematol; 2002 Jan; 30(1):89-96. PubMed ID: 11823042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective depletion of CD11c
    Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
    Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The contribution of cytotoxic and noncytotoxic function by donor T-cells that support engraftment after allogeneic bone marrow transplantation.
    Jiang Z; Adams GB; Hanash AM; Scadden DT; Levy RB
    Biol Blood Marrow Transplant; 2002; 8(11):588-96. PubMed ID: 12463477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.
    Yang J; Gao L; Liu Y; Ren Y; Xie R; Fan H; Qian K
    Transfusion; 2010 Feb; 50(2):407-17. PubMed ID: 19788510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.